Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix

J Virol. 1995 Mar;69(3):1984-9. doi: 10.1128/JVI.69.3.1984-1989.1995.

Abstract

Incorporation of envelope glycoproteins into a budding retrovirus is an essential step in the formation of an infectious virus particle. By using site-directed mutagenesis, we identified specific amino acid residues in the matrix domain of the human immunodeficiency virus type 1 (HIV-1) Gag protein that are critical to the incorporation of HIV-1 envelope glycoproteins into virus particles. Pseudotyping analyses were used to demonstrate that two heterologous envelope glycoproteins with short cytoplasmic tails (the envelope of the amphotropic murine leukemia virus and a naturally truncated HIV-2 envelope) are efficiently incorporated into HIV-1 particles bearing the matrix mutations. Furthermore, deletion of the cytoplasmic tail of HIV-1 transmembrane envelope glycoprotein gp41 from 150 to 7 or 47 residues reversed the incorporation block imposed by the matrix mutations. These results suggest the existence of a specific functional interaction between the HIV-1 matrix and the gp41 cytoplasmic tail.

MeSH terms

  • Cytoplasm
  • Gene Products, gag / metabolism*
  • HIV Envelope Protein gp41 / metabolism
  • HIV-1 / ultrastructure*
  • HIV-2 / ultrastructure
  • HeLa Cells
  • Humans
  • Leukemia Virus, Murine / ultrastructure
  • Morphogenesis
  • Mutagenesis, Site-Directed
  • Sequence Deletion
  • Structure-Activity Relationship
  • Viral Envelope Proteins / metabolism*
  • Virion / metabolism
  • Virus Replication

Substances

  • Gene Products, gag
  • HIV Envelope Protein gp41
  • Viral Envelope Proteins